Observation of clinical efficacy of cassava RS3 resistant starch in treating patients with atherosclerotic cerebral infarction during recovery
10.3969/j.issn.1673-9701.2025.32.014
- VernacularTitle:蕉芋RS3型抗性淀粉治疗动脉粥样硬化性脑梗死恢复期患者的临床疗效观察
- Author:
Yuanhua WU
1
;
Xianhui HUANG
;
Xueyong WANG
;
Bingjie CHEN
;
Yu PENG
;
Lulu LI
Author Information
1. 贵州中医药大学第一附属医院神经内科,贵州贵阳 550001
- Publication Type:Journal Article
- Keywords:
Cassava RS3 resistant starch;
Atherosclerotic;
Homocysteine infarction
- From:
China Modern Doctor
2025;63(32):58-61
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate effect of cassava RS3 resistant starch(Ce-RS3)on serum homocysteine(Hcy)level in patients with atherosclerotic cerebral infarction(ACI)during the recovery period.Methods A total of 55 patients with ACI at the First Affiliated Hospital of Guizhou University of Traditional Chinese Medicine from October 2023 to October 2024 were selected as subjects.They were devieded into observation group(n=28)and control group(n=27)using a random number table.The control group received atorvastatin calcium,phospholipids,and aspirin,while the observation group received atorvastatin calcium,phospholipids,aspirin,and Ce-RS3.After 12 weeks of treatment,homocysteine(Hcy)levels,carotid plaque diameter,National Institutes of Health stroke scale(NIHSS)scores,Barthel index(BI)scores,and traditional Chinese medicine(TCM)syndrome scores were compared between two groups.Results After treatment,the serum Hcy levels decreased and carotid plaque size reduced in both groups,with the NIHSS scores and TCM syndrome scores also decreased,and observation group was lower than control group(P＜0.05).After treatment,the BI score increased,with observation group higher than control group(P＜0.05).Conclusion The use of Ce-RS3 in the recovery phase of patients with ACI can effectively improve neurological function and enhance treatment efficacy.
